Pfizer Vaccine for Kids Aged 5 to 11 to Be Evaluated by EMA. Vaccine Makers’ Stocks Are Mixed.

Pfizer Vaccine for Kids Aged 5 to 11 to Be Evaluated by EMA. Vaccine Makers’ Stocks Are Mixed.
·1 min read

The European Medicines Agency is evaluating an application to extend the Pfizer Covid-19 vaccine to children aged 5 to 11.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting